Limitations of quantiferon-TB gold assay for screening of psoriasis patients prior to anti-tumour necrotic factor treatment

Alessandra BuaDepartment of Biomedical Sciences, Section of Experimental and Clinical Microbiology, University of Sassari, Sassari, Italy; Correspondence[email protected]

Stefania ZanettiDepartment of Biomedical Sciences, Section of Experimental and Clinical Microbiology, University of Sassari, Sassari, Italy;

Maria Francesca PeigottuDermatology Unit, Department of Surgical, Microsurgical and Medical Sciences, University of Sassari, Sassari, Italy;

Maria Antonetta MontesuDermatology Unit, Department of Surgical, Microsurgical and Medical Sciences, University of Sassari, Sassari, Italy;

Paola MolicottiDepartment of Biomedical Sciences, Section of Experimental and Clinical Microbiology, University of Sassari, Sassari, Italy;

Click to increase image sizeClick to decrease image size

Disclosure statement

The authors declare that they have no conflicts of interest.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Limitations of quantiferon-TB gold assay for screening of psoriasis patients prior to anti-tumour necrotic factor treatment

Information for

Open access

Opportunities

Help and information

Limitations of quantiferon-TB gold assay for screening of psoriasis patients prior to anti-tumour necrotic factor treatment

Disclosure statement

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Your download is now in progress and you may close this window

Login or register to access this feature